These days, one of the hottest topics in the tech and medical industries is the matter of cybernetics or merging man with machine. A scientist has recently advanced this field by demonstrating how a brain implant can improve memory. The breakthrough could also have several potential benefits, including treating epilepsy.
The findings were recently presented by University of Southern California research Dong Song to a gathering of scientists at the Society for Neuroscience, which was held in Washington D.C., New Scientist reports. The implant basically involves putting electrodes on the brain that will then mimic how humans process memories.
As a result, the implants are actually able to boost memory by up to 30 percent, according to Song. Presented as something like a “memory prosthesis,” the test used 20 volunteers to prove that it can actually be done.
During the experiments, the scientists basically determined when the brain’s memory is working at optimal levels. When it happens, the electrodes stimulate the brain, which then boosts memory. This could have a significant impact on humanity simply because, while the human brain is excellent at storing memory, actually retrieving it is a different matter.
As Futurism notes, this development is also crucial for those who are suffering from degenerative neurological conditions such as dementia and Alzheimer’s. While the root cause for those particular diseases has not been conclusively discovered yet, the prospect of maintaining optimal memory via a brain implant would stave off the worst effects of the conditions.
Taking care of patients with neurological illnesses is a costly affair as well, with yearly expenses stacking up to reach $236 billion. Putting implants in brains would be a huge step towards not only improving the memory of humans, in general, but also to make sure that patients at risk of losing their core memories have more time to live a healthy life.


Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Neuralink Expands Brain Implant Trials with 12 Global Patients
Australia Releases New National AI Plan, Opts for Existing Laws to Manage Risks
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Sam Altman Reportedly Explored Funding for Rocket Venture in Potential Challenge to SpaceX
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
Apple Leads Singles’ Day Smartphone Sales as iPhone 17 Demand Surges
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum
Amazon and Google Launch New Multicloud Networking Service to Boost High-Speed Cloud Connectivity
Quantum Systems Projects Revenue Surge as It Eyes IPO or Private Sale
TSMC Accuses Former Executive of Leaking Trade Secrets as Taiwan Prosecutors Launch Investigation
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Apple Appoints Amar Subramanya as New Vice President of AI Amid Push to Accelerate Innovation 



